NCT03430050View on ClinicalTrials.gov

Progesterone for Cannabis Withdrawal

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 16, 2017

Primary Completion Date

April 4, 2018

Study Completion Date

April 4, 2018

Conditions
Cannabis Use DisorderCannabis Withdrawal
Interventions
DRUG

Progesterone

Progesterone capsule

DRUG

Placebo

Placebo capsule. Manufactured to mimic progesterone 200mg capsule.

Trial Locations (1)

29403

Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

Medical University of South Carolina

OTHER

NCT03430050 - Progesterone for Cannabis Withdrawal | Biotech Hunter | Biotech Hunter